Active HealthCare Stock Watch: Leading Pharma Company Gets New Patents Approved
14 Février 2013 - 5:28PM
Marketwired
"Active HealthCare Companies Watch" for today: Crown Marketing
Pharmaceuticals (OTCQB: CWNM), YaFarm Technologies, Inc.
(PINKSHEETS: YFRM), GrowLife, Inc. (OTCQB: PHOT) and Bond
Laboratories, Inc. (OTCQB: BNLB)
Crown Marketing Pharmaceuticals (OTCQB: CWNM) announced today
that Patents for its Controlled Drug Delivery Technology (CDDT)
have been approved and registered in South Africa. This is CWNM's
second major announcement regarding the approval of new Patents
following last week's news it had also secured Patents in Norway.
Read the full release with company disclosures at
http://www.financialnewsmedia.com/stock-investing-business-investing-news/featured-news.php?id=250
Crown is continuing to secure its worldwide patent rights as it
pursues novel applications of its drug delivery technology. CWNM
also announced last week on February 7th the company has begun to
review positive in vivo test results by examining blood plasma
levels in test subjects using Crown's Controlled Drug Delivery
Technology (CDDT). A clinical trial was conducted using 300 mg of
Dexibuprofren Lysine and found that the blood plasma levels tracked
the in vitro test results conducted earlier. The clinical trial
appears to validate our belief and claims that because of the
controllable diffusion dynamics and our mathematical modeling, we
can predict with a high degree of certainty the release kinetics.
For more details regarding Crown's CDDT applications, go to
http://crowncddt.com/technology/
Stay informed on Crown Marketing developments by getting FREE
news alerts & updates delivered directly to your mobile phone
by texting STOCK to 545454 from your cellular device or visit
http://cwnm.mobi for more details.
YaFarm Technologies, Inc. (PINKSHEETS: YFRM) announced this week
that The Integrative Stem Cell Institute (ISCI), a premier provider
of point-of-care, stem cell-based therapies, has launched a global
physician's network, to connect international patients to local
physicians, and to link physicians to opportunities for education,
training and collaboration in regenerative medicine.
GrowLife, Inc. (OTCQB: PHOT), a provider of highly effective
indoor growing technologies, announced this week that it has
engaged Medicus Research, LLC to provide a comprehensive review of
worldwide scientific literature on the therapeutic benefits of
medical marijuana. Medicus Research is a premier organization
engaged in clinical trials across various disciplines and is
uniquely staffed to concentrate on early stage botanical drugs and
the related published medical literature.
Bond Laboratories, Inc. (OTCQB: BNLB), an international provider
of innovative and proprietary nutritional supplements for health
conscious consumers marketed primarily through its wholly owned
operating division, NDS Nutrition Products ("NDS"), recently
announced that the Company is introducing another new, cutting edge
product, EvoLean™, to its impressive list of effective diet and
weight loss formulations. BNLB is trading up early today at $0.11
on over 2.5 Million shares traded since 10:30am on 2/14/13.
FinancialNewsMedia.com is
leading provider of third party publishing & news dissemination
services. If you would like more information regarding our news
coverage solutions, please visit http://www.financialnewsmedia.com for
more details.
DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher
and news dissemination service provider, which disseminates
electronic information through multiple online media channels. FNMG
is NOT affiliated in any manner with any company mentioned herein.
FNMG and its affiliated companies are a news dissemination and
financial marketing solutions provider and are NOT a registered
broker/dealer/analyst/adviser, holds no investment licenses and may
NOT sell, offer to sell or offer to buy any security. FNMG's market
updates, news alerts and corporate profiles are NOT a solicitation
or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly
informational and is NEVER to be construed or interpreted as
research material. All readers are strongly urged to perform
research and due diligence on their own and consult a licensed
financial professional before considering any level of investing in
stocks. The companies that are discussed in this release may or may
not have approved the statements made in this release. FNMG is not
liable for any investment decisions by its readers or subscribers.
Investors are cautioned that they may lose all or a portion of
their investment when investing in stocks.
To comply with Section 17(b) of the Securities Act of 1933, FNMG
shall always disclose any compensation it has received, or expects
to receive in the future, for the dissemination of the information
found herein on behalf of one or more of the companies mentioned in
this release. For disseminating this release, FNMG expects to be
compensated one thousand five hundred dollars for coverage of this
news release by a non-affiliated third party company. FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE
AND WAS NOT COMPENSATED BY ON OTHER COMPANY INCLUDED
HEREIN.
This release contains "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E the Securities Exchange Act of 1934, as amended and
such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. "Forward-looking statements" describe future expectations,
plans, results, or strategies and are generally preceded by words
such as "may," "future," "plan" or "planned," "will" or "should,"
"expected," "anticipates," "draft," "eventually" or "projected."
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors, and other risks
identified in a company's annual report on Form 10-K or 10-KSB and
other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this
release are made as of the date hereof and FNMG undertakes no
obligation to update such statements.
Contact Information: Company: FN Media Group, LLC Contact email:
Email Contact U.S. Phone: 1(954)345-0611 URL:
http://www.financialnewsmedia.com
Profile Solutions (CE) (USOTC:PSIQ)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Profile Solutions (CE) (USOTC:PSIQ)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024